SGCA
protein-codingsarcoglycan alpha
Gene summary
This gene encodes a component of the dystrophin-glycoprotein complex (DGC), which is critical to the stability of muscle fiber membranes and to the linking of the actin cytoskeleton to the extracellular matrix. Its expression is thought to be restricted to striated muscle. Mutations in this gene result in type 2D autosomal recessive limb-girdle muscular dystrophy. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008]
- ADL
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~11.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0011968
Submitter: Laboratory for Molecular Medicine
This gene-disease relationship has undergone rapid assessment. Classifications are based on preliminary review of gene-disease validity during analysis of genomic sequencing results.
Inheritance Pattern: AR
Disease ID:MONDO:0011968
Submitter: Natera
Inheritance Pattern: AR
Disease ID:MONDO:0011968
Submitter: Myriad Women's Health
Inheritance Pattern: AR
Disease ID:MONDO:0015152
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0015152
Submitter: ClinGen
Evidence indicating a relationship between variants in SGCA and autosomal recessive muscular dystrophy was reported by Roberds et al., 1994 (PMID: 8069911), in which variants in SGCA were found to segregate in a large French family that showed linkage analysis implicating chromosome 17 with limb girdle muscular dystrophy (Romero et al., 1994; PMID: 7987694). Limb girdle muscular dystrophy (LGMD) is characterized by progressive muscle weakness of proximal limb with age, which can lead to difficulty walking or complete loss of ambulation requiring wheel chair use. Other phenotypic features associated include scapular winging, calf pseudo hypertrophy, contractors, and in some cases cardiomyopathy (PMID: 22303798, 19781108 ). Numerous variants have been reported, in both ClinVar and in LOVD (https://databases.lovd.nl/shared/genes/SGCA). Further, the p.Arg77Cys variant is a known founder variant and has been estimated to account for ~30% of autosomal recessive LGMD associated with SGCA (PMID: 9192266, 15736300, 8528203). Evidence supporting this gene-disease relationship includes case-level data, segregation data, functional data, and model organisms. This gene-disease relationship has been studied for more than 20 years, therefore a significant amount of case-level data, segregation data, and experimental data is available, however the maximum score for genetic evidence (12 points) and experimental evidence (6 points) has been reached. The mechanism for the gene-disease relationship is protein loss of function, as SGCA encodes alpha-sarcoglycan, an essential component of the dystrophin-glycoprotein complex (PMID: 19781108) present in striated muscle costameres which function in muscle contraction. In summary, SGCA is definitively associated with autosomal recessive limb girdle muscular dystrophy (MONDO:0015152). This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Limb-Girdle Muscular Dystrophy GCEP on 02/07/20 (SOP Version 7). This gene curation was re-approved and published on 11/14/24 by the Muscular Dystrophies and Myopathies GCEP to reflect the change in the panel's name from LGMD GCEP to MDM GCEP. As part of this process, the genetic evidence was re-scored in accordance with SOP version 11.
Inheritance Pattern: AR
Disease ID:MONDO:0011968
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0011968
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Musculoskeletal
Intervention: Cardiovascular
Rationale: The condition can include severe cardiac manifestations, and knowledge may allow surveillance (eg, with EKG, echocardiogram, and Holter monitoring) and early medical management, which may ameliorate morbidity and mortality; Heart transplantation may be indicated in individuals with severe dilated cardiomyopathy
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SGCA variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000023.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 13 | 208 | 1 | 223 | |
| missense | 16 | 67 | 193 | 13 | 1 | 290 |
| nonsense | 9 | 15 | 24 | |||
| start loss | 2 | 2 | ||||
| frameshift | 31 | 46 | 1 | 78 | ||
| splice donor/acceptor (+/-2bp) | 6 | 26 | 3 | 35 | ||
| Total | 62 | 157 | 210 | 221 | 2 | 652 |
Highest pathogenic variant AF is 0.00046966044
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000014.1 | 9 | MANE Select | |
| Ensembl | ENSP00000262018.3 | 9 | MANE Select | |
| RefSeq | NP_001129169.1 | 7 | Standard | |
| Ensembl | ENSP00000345522.6 | 7 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Dilated cardiomyopathy (DCM) - Homo sapiens (human)
- Viral myocarditis - Homo sapiens (human)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens (human)
- Hypertrophic cardiomyopathy (HCM) - Homo sapiens (human)
- Arrhythmogenic Right Ventricular Cardiomyopathy
Biological Process
- muscle contraction
- muscle organ development
Molecular Function
- calcium ion binding
- protein binding
Cellular Component
- cytoplasm
- cytoskeleton
- cell-cell junction
- dystrophin-associated glycoprotein complex
- sarcoglycan complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000262018
- Coding exons
- 9
- Length
- 11718
- Individuals with no LoFs
- 125721
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 27
- Defined
- 125748
- p
- 0.000107
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.676 | 214 | 244 | 0.878 | 0.0000162 | 2445 |
| Missense (PolyPhen) | 68 | 85.262 | 0.79754 | 880 | ||
| Synonymous | 0.108 | 99 | 100 | 0.986 | 0.00000648 | 836 |
| Loss of Function | 2.19 | 7 | 16.7 | 0.420 | 8.08e-7 | 181 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00019 | 0.00018 | rare |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00022 | 0.00022 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00016 | 0.00016 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Component of the sarcoglycan complex, a subcomplex of the dystrophin-glycoprotein complex which forms a link between the F-actin cytoskeleton and the extracellular matrix.;
Recessive Scores
- pRec
- 0.103
Intolerance Scores
- LoFtool
- 0.0528
- RVIS EVS
- -0.71
- RVIS percentile EVS
- 14.5
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.554
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |